Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

sun pharma uk ltd - buprenorphine hydrochloride - sublingual tablet - 8mg

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

pilsco ltd - buprenorphine hydrochloride - sublingual tablet - 8mg

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

merck serono limited - glyceryl trinitrate - sublingual spray - 400 microgram - organic nitrates

Irlanda - inglês - HPRA (Health Products Regulatory Authority)

pco manufacturing - glyceryl trinitrate - sublingual spray - 400 microgram - glyceryl trinitrate

Malta - inglês - Medicines Authority

g. pohl-boskamp gmbh & co. kg kieler strasse 11, d-25551, hohenlockstedt, germany - glyceryl trinitrate - sublingual spray - glyceryl trinitrate 0.4 mg - cardiac therapy

Malta - inglês - Medicines Authority

medicem limited - glyceryl trinitrate - sublingual spray - glyceryl trinitrate 400 µg - cardiac therapy

Estados Unidos - inglês - NLM (National Library of Medicine)

espero pharmaceuticals, inc. - nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3) - nitroglycerin 400 ug - nitrolingual pumpspray is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. do not use nitrolingual pumpspray in patients who are taking pde-5-inhibitors, such as avanafil, sildenafil, tadalafil, or vardenafil. concomitant use can cause severe hypotension, syncope, or myocardial ischemia [see drug interactions (7.1) ]. do not use nitrolingual pumpspray in patients who are taking soluble guanylate cyclase (sgc) stimulators, such as riociguat. concomitant use can cause hypotension. nitrolingual pumpspray is contraindicated in patients with severe anemia (large doses of nitroglycerin may cause oxidation of hemoglobin to methemoglobin and could exacerbate anemia). nitrolingual pumpspray  may precipitate or aggravate increased intracranial pressure and thus should not be used in patients with possible increased intracranial pressure (e. g. cerebral hemorrhage or traumatic brain injury). nitrolingual pumpspray is contraindicated in patients who are allergic t

Estados Unidos - inglês - NLM (National Library of Medicine)

first horizon pharmaceutical corporation - nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3) - spray - 400 ug - nitrolingual® pumpspray is indicated for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. allergic reactions to organic nitrates are rare.  nitroglycerin is contraindicated in patients who are allergic to it.  nitrolingual® pumpspray is contraindicated in patients taking certain drugs for erectile dysfunction (phosphodiesterase inhibitors), as their concomitant use can cause severe hypotension.  the time course and dose-dependency of this interaction are not known. safety and effectiveness of nitroglycerin in pediatric patients have not been established.

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

indivior uk ltd - buprenorphine hydrochloride - sublingual tablet - 400microgram

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

eumedica pharmaceuticals ag - buprenorphine hydrochloride - sublingual tablet - 400microgram